✦ LIBER ✦

Daclizumab is associated with decreased rejection and improved patient survival in renal transplant recipients

✍ Scribed by JA Morris; JE Hanson; BJ Steffen; AH Chu; KS Chi-Burris; VP Gotz; RD Gordon

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Zenapax (daclizumab) reduces the inciden

✍ H Ekberg; L Bäckman; G Tufveson; G Tydén 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Daclizumab is Associated With Decreased

✍ J. Kobashigawa; K. David; J. Morris; A.H. Chu; B.J. Steffen; V.P. Gotz; R.D. Gor 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 305 KB

Can daclizumab reduce acute rejection an

✍ CHI YUEN CHEUNG; YAN LUN LIU; KIM MING WONG; HOI WONG CHAN; YIU HAN CHAN; HO SIN 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

Mycophenolate mofetil vs. azathioprine i

✍ Kristin M David; Jonathan A Morris; Bettina J Steffen; Kathy S Chi-Burris; Vince 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

Mycophenolate Mofetil Use Is Associated

✍ R. H. Wiesner; B. J. Steffen; K. M. David; A. H. Chu; R. D. Gordon; J. R. Lake 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

Cellular rejection in liver transplantat

✍ N. Maharaj; P. Dewan; Nancy Rolando; David Patch; Brian Davidson; Keith Rolles; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 111 KB